Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

A2a Pharmaceuticals Inc.

Clinical trials sponsored by A2a Pharmaceuticals Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug AO-252 targets Hard-to-Treat cancers in early trial Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New drug AO-252 targets Hard-to-Treat cancers in early trial

Disease control Recruiting now

This early-stage study tests a new drug called AO-252 in people with advanced solid tumors, including those that have spread to the brain. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors or stop them from growing. About 86 adults whos…

Phase 1 • Sponsor: A2A Pharmaceuticals Inc. • Aim: Disease control

Last updated Aug 19, 2026 00:00 UTC